1. Home
  2. TURB vs INTS Comparison

TURB vs INTS Comparison

Compare TURB & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turbo Energy S.A.

TURB

Turbo Energy S.A.

BUY

Current Price

$1.02

Market Cap

14.1M

Sector

N/A

ML Signal

BUY

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.71

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TURB
INTS
Founded
2013
2012
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
13.7M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
TURB
INTS
Price
$1.02
$3.71
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $19.33
AVG Volume (30 Days)
★ 2.4M
13.7K
Earning Date
09-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.22
52 Week High
$6.50
$8.06

Technical Indicators

Market Signals
Indicator
TURB
INTS
Relative Strength Index (RSI) 43.93 45.72
Support Level $0.99 $0.30
Resistance Level $1.22 $4.30
Average True Range (ATR) 0.16 0.30
MACD 0.00 -0.02
Stochastic Oscillator 2.80 45.41

Price Performance

Historical Comparison
TURB
INTS

About TURB Turbo Energy S.A.

Turbo Energy SA is an integrator of AI-driven energy storage and intelligent energy management solutions focused on transforming how energy is generated, stored, optimized, and consumed across residential, commercial, industrial, and utility-scale applications. It operates at the intersection of renewable energy infrastructure, energy storage, and software-driven optimization, combining battery systems, solar integration, and proprietary Artificial Intelligence (AI) technologies into unified intelligent energy platforms. Its solutions are designed to help customers reduce energy costs, improve operational resilience, increase energy independence, and optimize energy performance in increasingly decentralized and volatile energy markets. It generates the majority of its revenue from Spain.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: